This chain of amino acids forms a cavity in the neuraminidase enzyme that facilitates H5N1's spread. Anti-flu drugs called neuraminidase inhibitors work by entering and binding to the hot pocket, almost like a hand fitting into a glove.
21/06/07 Amid heightened concern over a possible epidemic of bird flu in humans, scientists in the United States and Taiwan are reporting critical new insights into the architecture of a key enzyme in the H5N1 avian influenza virus that enables the virus to spread.
Rommie E. Amaro and colleagues focused on what has been termed the "hot pocket," or more technically "the 150-loop." This chain of amino acids forms a cavity in the neuraminidase enzyme that facilitates H5N1's spread. Anti-flu drugs called neuraminidase inhibitors work by entering and binding to the hot pocket, almost like a hand fitting into a glove.
In the new study, researchers report that the hot pocket actually can have internal shapes substantially different than previously believed. That new structural understanding of the 150-loop could be valuable in efforts to design new and more effective anti-flu drugs, they state. Drugs capable of fitting more snugly into the cavity could yield a class of neuraminidase inhibitors that are more effective against H5N1-like flu viruses.

Upcoming webinars

Introducing LifeChews® and the Next Generation of Plant-based Supplements
Sirio

Why ARA & DHA matter: Key lipids shaping infant development
dsm-firmenich

Where Structure Drives Beauty: From Scalp Health to Skin Radiance
Monteloeder










